Document Detail

The value of prophylactic antibiotics in aorat-coronary bypass operations: a double-blind randomized trial.
MedLine Citation:
PMID:  388085     Owner:  NLM     Status:  MEDLINE    
Prospective and retrospective studies were performed to determine the efficacy of prophylactic antibiotics in preventing infections in patients undergoing arota-coronary bypass. One-hundred five patients were randomized in a double-blind fashion to receive either methicillin or saline-placebo for 3 days. The over-all infection rate was 26.7% with 48.9% in the control group and 8.6% in the methicillin group (p less than 0.001). Significant sternal wound infection developed in 21.3% of the control group and 0% of the methicillin group (p less than 0.01). Staphylococcus aureus was the predominant organism causing significant sternal infection (methicillin group versus control group, 5.2% and 21.3%; p less than 0.05). The length of postoperative stay in hospital and the number of days with fever was significantly greater in the control group than in the methicillin group (p less than 0.001). During the same period of time, 160 patients were studied retrospectively. Of these, 150 patients received cephalothin prophylaxis and 10 received methicillin. Comparison of the rates of infection in the cephalothin group to the total methicillin group (prospective and retrospective) showed no significant difference. The study clearly demonstrated that a short course of prophylactic antistaphlococcal penicillin or cephalosporin is justified in aorta-coronary bypass.
I W Fong; C B Baker; D C McKee
Related Documents :
10551755 - Microbiology of subphrenic abscesses: a 14-year experience.
10533765 - Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of int...
10224345 - Long-acting versus short-acting cephalosporins for preoperative prophylaxis in breast s...
21937525 - Safety and self-reported efficacy of botulinum toxin for adult spasticity in current cl...
8887015 - Therapeutic benefit of benfluorex in type ii diabetic patients treated with sulfonylureas.
23014355 - Presumed hydrogen sulfide-mediated neurotoxicity after streptococcus anginosus group me...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  78     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1979 Dec 
Date Detail:
Created Date:  1980-01-28     Completed Date:  1980-01-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  908-13     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cephalothin / therapeutic use
Clinical Trials as Topic
Coronary Artery Bypass / methods*
Coronary Disease / surgery
Double-Blind Method
Methicillin / therapeutic use*
Middle Aged
Postoperative Complications / etiology
Prospective Studies
Random Allocation
Retrospective Studies
Staphylococcal Infections / prevention & control
Surgical Wound Infection / etiology,  prevention & control*
Urinary Tract Infections / etiology
Reg. No./Substance:
153-61-7/Cephalothin; 61-32-5/Methicillin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adriamycin in localized and metastatic uterine sarcomas.
Next Document:  Chlamydial infections. Microbiological, clinical and diagnostic aspects.